46
Participants
Start Date
April 24, 2022
Primary Completion Date
June 25, 2023
Study Completion Date
May 31, 2026
SBRT
Stereotactic body radiation therapy delivered with a fixed dose (8Gy) in 3 daily fractions 1-7 days before the first cycle of immunochemotherapy
Tislelizumab
200mg q3w for two cycles administrated concurrently with chemotherapy
Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University
OTHER